Department of Health and Human Services

Part 1. Overview Information

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute of Dental and Craniofacial Research (NIDCR)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute of Nursing Research (NINR)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)

Funding Opportunity Title
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Activity Code

R15 Research Enhancement Award

Announcement Type
Reissue of PAR-19-134
Related Notices

See Notices of Special Interest associated with this funding opportunity

  • March 4, 2022 - Notice of Participation of National Institute on Minority Health and Health Disparities (NIMHD) in PAR-22-060. See Notice NOT-MD-22-013.
  • January 18, 2022 - Notice of Information Regarding Eligibility of Schools of Engineering for Research Enhancement Award Program (REAP) Funding Opportunity Announcements. See Notice NOT-GM-22-028.
  • NOT-OD-22-018 - Reminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2022 - New Grant Application Instructions Now Available

    NOT-OD-21-181 - Updates to the Non-Discrimination Legal Requirements for NIH Recipients

    NOT-OD-21-169 - New NIH "FORMS-G" Grant Application Forms and Instructions Coming for Due Dates on or after January 25, 2022

    NOT-OD-21-170 - Update: Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements

    NOT-OD-21-109 - Expanding Requirement for eRA Commons IDs to All Senior/Key Personnel

    Funding Opportunity Announcement (FOA) Number
    PAR-22-060
    Companion Funding Opportunity
    PAR-21-357 , R15 Academic Research Enhancement Awards (AREA)
    Assistance Listing Number(s)
    93.121, 93.866, 93.867, 93.853, 93.361, 93.855, 93.213, 93.172, 93.286, 93.865, 93.273, 93.846, 93.279, 93.173, 93.113, 93.242, 93.351, 93.838, 93.837, 93.839, 93.840, 93.233, 93.393, 93.394, 93.395, 93.399
    Funding Opportunity Purpose

    The purpose of the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for health professional, undergraduate and graduate students and enhancing the research environment at applicant institutions.

    Eligible institutions must award baccalaureate or advanced science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F&A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the schools and colleges within the institution as a whole.

    Help determining the Organization Funding Level can be found here or https://grants.nih.gov/grants/funding/r15.htm.

    Key Dates

    Posted Date
    January 10, 2022
    Open Date (Earliest Submission Date)
    January 25, 2022
    Letter of Intent Due Date(s)

    Not Applicable

    The following table includes NIH standard due dates marked with an asterisk.
    Application Due Dates Review and Award Cycles
    New Renewal / Resubmission / Revision (as allowed) AIDS Scientific Merit Review Advisory Council Review Earliest Start Date
    February 25, 2022 * February 25, 2022 * May 07, 2022 * July 2022 October 2022 December 2022
    June 25, 2022 * June 25, 2022 * September 07, 2022 * November 2022 January 2023 April 2023
    October 25, 2022 * October 25, 2022 * January 07, 2023 * March 2023 May 2023 July 2023
    February 25, 2023 * February 25, 2023 * May 07, 2023 * July 2023 October 2023 December 2023
    June 25, 2023 * June 25, 2023 * September 07, 2023 * November 2023 January 2024 April 2024
    October 25, 2023 * October 25, 2023 * January 07, 2024 * March 2024 May 2024 July 2024
    February 25, 2024 * February 25, 2024 * May 07, 2024 * July 2024 October 2024 December 2024
    June 25, 2024 * June 25, 2024 * September 07, 2024 * November 2024 January 2025 April 2025
    October 25, 2024 * October 25, 2024 * January 07, 2025 * March 2025 May 2025 July 2025

    All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

    Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

    Expiration Date
    January 08, 2025
    Due Dates for E.O. 12372

    Not Applicable

    Required Application Instructions

    It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide,except where instructed to do otherwise (in this FOA or in a Notice from NIH Guide for Grants and Contracts ).

    Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.

    Applications that do not comply with these instructions may be delayed or not accepted for review.

    There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.

    1. Use the NIH ASSIST system to prepare, submit and track your application online.
    2. Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.

    3. Use Grants.gov Workspace to prepare and submit your application and eRA Commons to track your application.


    4. Table of Contents

    Part 2. Full Text of Announcement

    Section I. Funding Opportunity Description

    )The National Institutes of Health (NIH) is continuing to make a special effort to stimulate research at educational institutions that provide baccalaureate and/or advanced degrees for a significant number of the Nation's research institutions that have not been major recipients of NIH support. Since Fiscal Year (FY) 1985 Congressional appropriations for the NIH have included funds for this initiative, known as the Academic Research Enhancement Award (AREA) program that was intended to focus on undergraduate institutions (PAR-21-155). To complement the AREA program, this funding opportunity announcement (FOA) specifically supports eligible health professional schools and graduate schools to provide research experiences to health professional, undergraduate and/or graduate students pursuing biomedical or behavioral research.

    The three objectives of this FOA are to: (1) provide support for meritorious research; (2) strengthen the research environment at these institutions; and (3) give health professional, undergraduate and/or graduate students an opportunity to gain significant biomedical research experience through active involvement in the research. For the purposes of this FOA, health professional schools and colleges are accredited institutions that provide education and training leading to a health professional degree, including but not limited to: BSN, MSN, DNP, MD, DDS, DO, PharmD, DVM, OD, DPT, DC, ND, DPM, MOT, OTD, DPT, MS-SLP, CScD, SLPD, AuD, MSPO, MSAT, and MPH. Eligible health professional schools/colleges may include schools or colleges of nursing, medicine, dentistry, osteopathy, pharmacy, veterinary medicine, public health, optometry, allied health, chiropractics, naturopathy, podiatry, rehabilitation medicine, physical therapy, orthotics & prosthetics, kinesiology, occupational therapy and psychology. Accreditation must be provided by a body approved for such purpose by the Secretary of Education.

    The REAP program will enable qualified scientists to receive support for small-scale research projects.  It is anticipated that investigators supported under the REAP program will benefit from the opportunity to conduct independent research; that the grantee institution will benefit from a research environment strengthened through REAP grants; and that students at recipient institutions will benefit from exposure to and participation in scientific research in the biomedical sciences so that they consider careers in biomedical research. The REAP FOA emphasizes the engagement and inclusion of health professional, undergraduates and/or graduate students in research. Since diversity strengthens the research environment, REAP projects are encouraged to recruit and include students from diverse backgrounds, including those from groups underrepresented in the biomedical research workforce. (See NOT-OD-20-031 and NOT-OD-22-019) .

    The research project must involve health professional, undergraduate and/or graduate students and the research team must be composed primarily of health professional, undergraduate and/or graduate students. Student involvement in the research project may include participation in the design of experiments and controls, collection and analysis of data, execution and troubleshooting of experiments, participation in research meetings, and discussion of future directions. When applicable, it is highly desirable that student participation also include presentation at local and/or national meetings, publication of journal articles, and collaborative interactions. The REAP is a research grant program, not a training or fellowship program. As such, applications should not include training plans such as didactic training or non-research activities relating to professional development. This FOA does not provide support for research at undergraduate-focused institutions, and investigators from those institutions should apply to PAR-21-155 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed). Additional information on R15 programs can be found at: NIH Research Enhancement Award (R15)

    A REAP application submitted to this FOA may include other investigators, such as collaborators or consultants, or other individuals such as high school students, post baccalaureate participants, postdoctoral fellows, or clinical fellows. However, involvement of such individuals does not fulfill the goal to engage health professional, undergraduate and/or graduate students in eligible environments to research.

    This FOA will support basic and/or human subjects research but will NOT support research meeting the NIH definition of a clinical trial. Applicants are strongly encouraged to refer to NIH guidance on clinical trials (Clinical Trial Requirements for Grants and Contracts) or consult with NIH staff before selecting a Funding Opportunity Announcement. Investigators wishing to propose a clinical trial should apply to the Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) funding opportunity (PAR-21-357).

    In addition, applicants are encouraged to consult the Frequently Asked Questions website and the NIH Research Enhancement Award R15 website for more information about this program.

     

    Institute/Center Specific Interests

    National Heart, Lung, and Blood Institute (NHLBI)

    The NHLBI supports basic and clinical research pertaining to the structure, function, and diseases of the cardiovascular system, lungs, blood and blood vessels, and sleep disorders. NHLBI supports clinical trial research that is mechanistic and/or efficacy focused, including behavioral, pharmacotherapeutic, device-based, and other intervention approaches. The NHLBI also supports research in stem cell biology and transplantation, transfusion medicine, and blood resources. The NHLBI carries out its mission through a number of research programs that provide support for projects ranging from studies at the molecular level to whole body studies in man and animals. Examples of research areas supported by the NHLBI include atherosclerosis, hypertension, cerebrovascular disease (directed at the dependent variable of blood, heart, or blood vessel), coronary heart disease, peripheral vascular diseases, arrhythmias, heart failure, and shock, congenital and rheumatic heart diseases, cardiomyopathies and infections of the heart, circulatory assistance, lung cell and molecular biology, chronic obstructive lung diseases, pediatric pulmonary diseases, cystic fibrosis, sleep-disordered breathing, asthma, fibrotic and immunologic lung diseases, acute respiratory failure, pulmonary vascular diseases, HIV-associated lung disorders and bone marrow suppression, bleeding and clotting disorders, disorders of the red blood cell such as sickle cell disease and Cooley's anemia, bone marrow failure syndromes, and blood resources.

    National Human Genome Research Institute (NHGRI)

    NHGRI supports the development of resources, approaches, and technologies that will accelerate genomic research on the structure of genomes, the biology of genomes, and the biology of disease; that will use genomics to advance the science of medicine; and that will incorporate genomics to improve the effectiveness of healthcare. NHGRI also supports genomic research in several cross-cutting areas, including the ethical, legal and societal implications of genomics and genetics research, bioinformatics, technology development, and research training and career development. In general, NHGRI supports studies that provide generalizable methods and knowledge. Applications for studies relevant only to a particular disease or organ system should be directed to the appropriate Institute or Center. NHGRI strongly encourages potential applicants to reach out to the listed scientific contact in the early stages of developing an application.

    National Institute on Aging (NIA)

    NIA will accept applications for research projects in areas within the Institute's mission that includes genetic, biological, behavior, social, and economic research on aging. In addition, NIA encourages applications on Alzheimer’s Disease (AD) and AD Related Dementias (ADRD). The NIA website (https://www.nia.nih.gov/) provides additional information. about the Institute mission and areas of research interest. For additional scientific program information and for pre-application guidance, a potential applicant is encouraged to contact the NIA Program Director (link) whose portfolio covers the scientific topic of interest.

    National Institute of Alcohol Abuse and Alcoholism (NIAAA)

    NIAAA supports basic, translational, and clinical research on the causes, consequences, prevention, diagnosis, progression, and treatment of alcohol-related problems across the lifespan. NIAAA encourages meritorious alcohol research projects in the broad areas of neuroscience and behavior, organ damage and other health effects, epidemiology and prevention, and treatment and recovery. Investigators who conduct original and innovative basic biomedical, social, behavioral, clinical, or population-based research directed toward eliminating health disparities are invited to apply to this FOA. Projects may include a focus on addressing disparities in disparity populations as a whole, a single health disparity population, or a subgroup within a health disparity population. Projects addressing the improvement of health in racial/ethnic minority populations (without a specific emphasis on disparities relative to other groups) are also accepted under this announcement. More information about NIAAA’s mission and research priorities is available in the NIAAA Strategic Plan at https://www.niaaa.nih.gov/strategic-plan. For specific programmatic questions, please contact the NIAAA point-of-contact listed in this FOA.

    National Institute of Allergy and Infectious Diseases (NIAID)
    NIAID supports basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases, with the goal of developing new therapies, vaccines, diagnostic tests, and other technologies. Research areas include microbiology and infectious diseases, AIDS and AIDS -related research, immunology, allergy, transplantation, radiation medical countermeasures,and biodefense.

    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    NIAMS supports research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. NIAMS also conducts and supports basic research on the normal structure and function of bones, joints, muscles, and skin. Basic research involves a wide variety of scientific disciplines, including immunology, genetics, molecular biology, structural biology, biochemistry, physiology, virology, and pharmacology. Clinical research includes rheumatology, orthopedics, dermatology, metabolic bone diseases, heritable disorders of bone and cartilage, inherited and inflammatory muscle diseases, and sports and rehabilitation medicine.

    NIAMS will accept applications for research projects in areas within the Institute's mission. Applications from institutions serving underrepresented groups and institutions with well-developed, documented programs promoting diversity in the biomedical, behavioral, and clinical research workforce are strongly encouraged to apply. The NIAMS website (https://www.niams.nih.gov/) provides information about the institute mission and areas of research interest (https://www.niams.nih.gov/about-niams/strategic-plan-fiscal-years-2020-2024). For additional scientific program information and for pre-application guidance, potential applicants are encouraged to contact the NIAMS Extramural Research Program Staff whose portfolio covers the scientific topic of interest (https://www.niams.nih.gov/grants-funding/funding-opportunities/supported-scientific-areas).

    National Institute of Biomedical Imaging and Bioengineering (NIBIB)
    The mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to improve human health by supporting the development of cutting-edge technologies and computational methods in Biomedical imaging and Bioengineering. NIBIB-funded innovations have broad impact and fundamentally change our ability to prevent, diagnose, and treat human disease. Under this FOA, NIBIB will fund research projects that can be generalized to multiple conditions and physiological contexts and that fall under one or more of its Scientific Program Areas.

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    The NICHD supports biological, behavioral, and clinical research related to conception and pregnancy, normal and abnormal development in childhood, reproductive health, population dynamics across the lifespan, and rehabilitation medicine. https://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areas-research/Pages/default.aspx.

    Research projects considered by funding by NICHD must fall within the scientific missions of the twelve Scientific Branches of the NICHD Division of Extramural Research (DER) or the National Center for Medical Rehabilitation Research (NCMRR). Information about those scientific missions and program staff contacts may be found on the web pages for the DER scientific branches at: http://www.nichd.nih.gov/about/org/der/branches/Pages/index.aspx and the NCMRR at: http://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx. Potential applicants are strongly encouraged to read these webpages for any updates in response to recent scientific advances or emerging public health topics.

    NICHD encourages applications that address its extramural program priorities and will consider how well research projects align with one or more of those priorities when making award decisions. A detailed list of NICHD high priority research areas may be found at https://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areas-research/Pages/priorities.asp.

    National Institute on Deafness and other Communication Disorders (NIDCD)

    NIDCD supports applications that proposes research projects in the normal and disordered processes of
    hearing, balance, taste, smell, voice, speech, and language. Applicants are strongly encouraged to learn
    more about NIDCD research areas at https://www.nidcd.nih.gov/research/extramural.

    National Institute of Dental and CraniofacialResearch (NIDCR)

    NIDCR supports research concerning the etiology, epidemiology, prevention, diagnosis, and treatment of dental, oral and craniofacial disorders and diseases. In this context, the NIDCR emphasizes research on caries and periodontal diseases; oral infections (viral, fungal, and bacterial) host-responses to oral infections, (e.g., innate and adaptive immune responses), biofilms and microbial ecology, genomics and proteomics; oral aspects of AIDS/HIV infection; head and neck cancers; craniofacial development, physiology and malformations; orofacial pain and other oral sensory and motor dysfunctions; salivary glands and disorders such as Sjögren's Syndrome; temporomandibular joint disorders; and restoration and regeneration of dental, oral and craniofacial structures.

    National Institute of Drug Abuse (NIDA)

    NIDA is the lead federal agency supporting scientific research on drug use and its consequences. Our mission is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. Applications considered for funding by the NIDA should address critical issues of neuroscience, genetics, behavior, prevention, treatment, epidemiology, etiology, health services, health disparities, data science, medications development, HIV/AIDS, and co-occurring opportunistic infections (e.g., hepatitis C) in substance using populations, or other research areas relevant to drug use and addiction. NIDA priorities are further described in the NIDA Strategic Plan (see https://www.drugabuse.gov/about-nida/strategic-plan/executive-summary) and on the NIDA Research Programs and Activities (see https://www.drugabuse.gov/research/nida-research-programs-activities). Applicants are encouraged to contact a program official to discuss the proposed application.

    National Institute of Environmental Health Sciences (NIEHS)

    NIEHS will accept applications describing research projects that will have a defined impact on the environmental health sciences and be responsive to both the mission of the NIH and, specifically, to the mission of the NIEHS and the NIEHS 2018-2023 Strategic Plan. This plan outlines themes and goals that reflect both the mission of the NIEHS, which is to promote healthier lives by discovering how the environment affects people, and the vision of NIEHS to provide global leadership for innovative research that improves public health by preventing disease and disability.

    A variety of scientific disciplines, including basic, mechanistic, clinical, epidemiological, computational, engineering, and/or health risk communication approaches, can be used to advance the NIEHS Strategic Plan. Applicants should consult the strategic plan to ensure the research proposed addresses the goals and priority areas of the NIEHS. Applications submitted to this FOA must have a research focus on exposure-health related responses from environmental agents within the mission interest of the NIEHS (e.g., industrial chemicals or manufacturing byproducts, metals, pesticides, herbicides, air pollutants and other inhaled toxicants, particulates or fibers, fungal, and bacterial or biologically derived toxins). Agents that are considered within the primary mission responsibility of other NIH Institutes and Centers include but are not limited to: alcohol; chemotherapeutic agents; radiation that is not a result of an ambient environmental exposure; smoking, except when considered as a secondary smoke exposure that is a component in the indoor environment (particularly in children); drugs of abuse; pharmaceuticals; dietary nutrients; and infectious or parasitic agents. Applications that focus entirely, or primarily, on these exposure factors will be not be considered for support by NIEHS.

    National Institute for Mental Health (NIMH)

    The mission of the National Institute of Mental Health (NIMH) is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure. Applications considered for funding by the NIMH must fall within the areas of priority detailed in the NIMH Strategic Plan and the NIMH Strategic Research Priorities. Applicants are strongly encouraged to contact the person listed under Agency Contacts (Section VII) prior to submission.

    National Institute on Minority Health and Health Disparities (NIMHD)

    The mission of the NIMHD is to lead scientific research to improve minority health and reduce health disparities. NIMHD supports the study of many aspects of minority health and health disparities— from biological and population sciences to clinical, behavioral, and translational research, as well as research on health care services, health systems and workforce development. NIMHD focuses on the full continuum of causes of health disparities and the interrelation of these causes. Projects must include a focus on one or more of the following NIH-designated populations that experience health disparities in the United States: African Americans, Latinos/Hispanics, American Indians and Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, less privileged socioeconomic groups, underserved rural populations, and sexual and gender minorities (SGMs). Comparison groups/populations may also be included as appropriate for the research questions posed. NIMHD encourages projects that use approaches encompassing multiple domains of influence (e.g., biological, behavioral, sociocultural, environmental, physical environment, health system) and multiple levels of influence (e.g., individual, interpersonal, family, peer group, community, societal) to understand and address health disparities (see the NIMHD Minority Health and Health DisparitiesResearch Framework, https://www.nimhd.nih.gov/about/overview/research-framework.html, for more information).

    NIMHD will not support animal studies under this FOA.

    The National Institute of Neurological Disorders and Stroke (NINDS)

    NINDS seeks fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. NINDS supports basic, translational and clinical research within specifically defined areas of neuroscience. Research projects considered for funding by NINDS must fall within the scientific research mission of the Institute. Applicants are strongly encouraged to contact the person listed under Agency Contacts (Section VII) early in the application preparation process to confirm the relevance of the proposed research to the NINDS mission and for preapplication guidance.

    National Institute of Nursing Research (NINR)

    The National Institute of Nursing Research (NINR) supports research that builds the scientific foundation for nursing practice and policy across clinical and community settings, and advances the prevention, detection, and management of disease and disability. Drawing on nursing’s holistic perspective, NINR funds research that integrates factors at multiple levels, including social determinants of health, to identify their role in health, health improvement, and health inequities. NINR promotes research that improves the health of individuals, families, and populations in a variety of settings, translating science in order to maximize the impact of findings on practice and policy. Advancing health equity is an area of high priority.

    National Center for Complementary and Integrative Health (NCCIH)

    The mission of NCCIH is to determine, through rigorous scientific investigation, the usefulness and safety of complementary health approaches, and their roles in improving health and healthcare. NCCIH’s strategic plan includes five major objectives: 1) Advance fundamental science and methods development; 2) Advance research on the whole person and on the integration of complementary and conventional care; 3) Foster research on health promotion and restoration, resilience, disease prevention, and symptom management; 4) Enhance the complementary and integrative health research workforce; and 5) Provide objective evidence-based information on complementary and integrative health interventions. In pursuit of these objectives, NCCIH supports research on complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body approaches); research on nutritional interventions including natural products; and studies of “real world” patterns and outcomes of use of complementary therapies. Studies in response to this FOA may range from basic, through translational, epidemiological, health services, and other human subjects research, but may not propose a clinical trial. Investigators are strongly encouraged to discuss their concepts with NCCIH program staff prior to applying.

    Office of Research Infrastructure Programs (ORIP)
    ORIP’s mission is to support research infrastructure and related programs, including research resources centers that provide animal models used to study the causes, treatment, and prevention of diseases. These resources benefit researchers supported by many NIH Institutes, Centers, and Offices (ICOs). ORIP also provides specialized biomedical research training for veterinary scientists.

    ORIP will accept applications from eligible health professional schools, with preference given to colleges of veterinary medicine, proposing comparative studies of a wide range of biological models to improve their value in translational research. Applications must not be categorical in nature (i.e., not organ specific or restricted to a single disease) and should be trans-NIH in scope, (i.e., encompassing the mission of two or more NIH ICOs). Projects also need to be responsive to both the mission of the NIH and of ORIP, as described in the ORIP 2021-2025 Strategic Plan. Applicants are strongly encouraged to reach out to ORIPs’ contact person prior to submission.

    Pre-consultation

    Participating NIH Institutes and Centers are listed on the first page of this announcement ("Components of Participating Organizations"). For additional scientific program information and for pre-application guidance, applicants are encouraged to contact the person listed for the participating NIH IC(s) with research interests relevant to the applicant's proposed topic. Consultation with relevant NIH staff prior to the application due date is strongly encouraged for new and resubmission applications. See Section VII. for contact information.

    See Section VIII. Other Information for award authorities and regulations.

    Section II. Award Information

    Funding Instrument

    Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.

    Application Types Allowed
    New
    Renewal
    Resubmission
    Revision

    The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.

    Clinical Trial?

    Not Allowed: Only accepting applications that do not propose clinical trials.

    Need help determining whether you are doing a clinical trial?

    Funds Available and Anticipated Number of Awards

    The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

    Award Budget

    Applicants may request up to $300,000 in direct costs for the entire project period of up to 3 years.

    Award Project Period

    The scope of the proposed project should determine the project period.  The maximum project period is 3 years.

    NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this FOA.

    Section III. Eligibility Information

    1. Eligible Applicants

    Eligible Organizations

    Higher Education Institutions

    • Public/State Controlled Institutions of Higher Education
    • Private Institutions of Higher Education

    The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

    • Hispanic-serving Institutions
    • Historically Black Colleges and Universities (HBCUs)
    • Tribally Controlled Colleges and Universities (TCCUs)
    • Alaska Native and Native Hawaiian Serving Institutions
    • Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)

    In addition, all organizations must meet the following two criteria at the time of submission:

    • The applicant organization must be an accredited public or non-profit private school that grants baccalaureate or advanced degrees in health professions (see section below for more details) or biomedical and behavioral sciences. The application must be submitted by the eligible organization with a unique entity identifier (such as DUNS) and a unique NIH eRA Institutional Profile File (IPF) number.
    • At the time of application submission, all components of the institution combined must not have received support from the NIH totaling more than $6 million per year (in both direct and F&A/indirect costs) in 4 of the last 7 years. A year is defined as a federal fiscal year: from October 1 through September 30. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all of the schools and colleges within the institution as a whole. Note that all activity codes are included in this calculation except the following: C06, S10, and all activity codes starting with a G.
    • For this FOA: Only eligible Health Professional or Graduate Institutions may apply
    • For this FOA: Non-health professional or non-graduate academic institutions are not eligible to apply
    • For the purposes of this FOA, a graduate school offers advanced degrees, beyond the undergraduate level, in an academic discipline including M.A., M.S., and Ph.D. degrees.
    • Health professional schools and colleges are accredited institutions that provide education and training leading to a health professional degree, including but not limited to: BSN, MSN, DNP, MD, DDS, DO, PharmD, DVM, OD, DPT, DC, ND, DPM, MOT, OTD, DPT, MS-SLP, CScD, SLPD, AuD, MSPO, MSAT, and MPH.
    • Eligible health professional schools/colleges may include schools or colleges of nursing, medicine, dentistry, osteopathy, pharmacy, veterinary medicine, public health, optometry, allied health, chiropractic, naturopathy, podiatry, rehabilitation medicine, physical therapy, orthotics & prosthetics, kinesiology, occupational therapy and psychology.  Accreditation must be provided by a body approved for such purpose by the Secretary of Education.
    • For institutions with multiple campuses, eligibility can be considered for each individual campus (e.g., main, satellite, etc.) only if a unique identifier number and NIH IPF number are established for each campus. For institutions that use one identifier number or NIH IPF number for all campuses, eligibility is determined for all campuses (e.g., main, satellite, etc.) together.

    Additional Eligibility Guidance

    A signed letter is required from the Provost or similar official with institution-wide responsibility verifying the eligibility of the applicant institution at the time of application submission according to the eligibility criteria indicated above. See the application instructions for "Other Attachments" on the SF424(R&R) Other Project Information form in Section IV.2 Instructions for Application Submission. Final eligibility will be validated by NIH prior to award.

    To assist in determining eligibility, organizations are encouraged to use the NIH RePORT website under NIH Awards by Location & Organization (http://projectreporter.nih.gov/reporter.cfm).   

    A REAP grant is permitted to have a subcontract to a non-REAP-eligible institution. However, applicants should keep the goals of the REAP program in mind when preparing the application, which include strengthening the research environment of eligible institutions and engaging students from eligible institutions to research. It is expected that the majority of the research will be directed by the PD(s)/PI(s) at the grantee institution.

    Undergraduate-focused institutions with undergraduate enrollment greater than graduate enrollment should apply to PAR-21-155, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed) or to PAR-21-154, Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15- Clinical Trial Required).

    Foreign Institutions

    Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.

    Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

    Foreign components, as defined in the NIH Grants Policy Statement, are allowed. 

    Required Registrations

    Applicant organizations

    Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.

    • Dun and Bradstreet Universal Numbering System (DUNS) - All registrations require that applicants be issued a DUNS number. After obtaining a DUNS number, applicants can begin both SAM and eRA Commons registrations. The same DUNS number must be used for all registrations, as well as on the grant application.
    • System for Award Management (SAM) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code.
    • eRA Commons - Applicants must have an active DUNS number to register in eRA Commons. Organizations can register with the eRA Commons as they are working through their SAM or Grants.gov registration, but all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
    • Grants.gov – Applicants must have an active DUNS number and SAM registration in order to complete the Grants.gov registration.

    Program Directors/Principal Investigators (PD(s)/PI(s))

    All PD(s)/PI(s) must have an eRA Commons account.  PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

    Eligible Individuals (Program Director/Principal Investigator)

    Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

    For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.

    To be eligible for an REAP grant, the PD(s)/PI(s) must meet the following additional criteria:

    • Each PD(s)/PI(s) must have a primary appointment at a health professional or graduate school or college within the applicant institution, as defined in "Eligible Institutions," above. If proposing multiple PD(s)/PI(s), each PD/PI must be at a REAP-eligible institution.
    • Each PD(s)/PI(s) may not be the PD(s)/PI(s) of an active NIH research grant, including another R15 grant, at the time of award of an REAP grant, although he or she may be one of the Key Personnel for an active NIH grant held by another PD/PI.
    • Each PD(s)/PI(s) may not be awarded more than one R15 grant at a time, although he or she may hold successive New or Renewal grants.

    2. Cost Sharing

    This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.

    3. Additional Information on Eligibility

    Number of Applications

    Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

    The NIH will not accept duplicate or highly overlapping applications under review at the same time, per 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

    • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
    • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
    • An application that has substantial overlap with another application pending appeal of initial peer review (see 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

    Section IV. Application and Submission Information

    1. Requesting an Application Package

    The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution.

    2. Content and Form of Application Submission

    It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

    Page Limitations

    All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

    Instructions for Application Submission

    The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing an application to this FOA.

    SF424(R&R) Cover

    All instructions in the SF424 (R&R) Application Guide must be followed.

    SF424(R&R) Project/Performance Site Locations

    All instructions in the SF424 (R&R) Application Guide must be followed.

    SF424(R&R) Other Project Information

    All instructions in the SF424 (R&R) Application Guide must be followed.

    Facilities & Other Resources: The following information should be included.

    • A profile of the students of the applicant institution and any information or estimate of the number who have obtained a health professional baccalaureate or advanced degree and gone on to obtain an academic or professional doctoral or other advanced degree in the health-related sciences during the last five years.
    • Description of plans to recruit students from diverse backgrounds, including those from groups underrepresented in the biomedical research workforce (See NOT-OD-20-031) to participate in the research project. Description of plans to encourage the participation of individuals from underrepresented racial and ethnic groups and individuals with disabilities to participate in the research project are also required (See NOT-OD-22-019).
    • Description of the special characteristics of the applicant institution that make it appropriate for an REAP grant awarded through this FOA, where the goals of this FOA are to: (1) provide support for meritorious research at health professional or graduate institution or institutional components; (2) strengthen the research environment at these institutions/components; and (3) give health professional, undergraduate and/or graduate students an opportunity to gain significant biomedical research experience through active involvement in the research.
    • Description of the likely impact of an REAP grant on the PD(s)/PI(s).
    • Description of the likely impact of an REAP grant on the research environment of the applicant institution.
    • Description of the likely impact of the REAP grant on the ability of health professional, undergraduate and/or graduate students at the institution to gain experience conducting biomedical research.
    • Provide a description of the resources of the grantee institution available for the proposed research (e.g., equipment, supplies, laboratory space, release time, matching funds, etc.).
    • Although the majority of the research must be directed by the PD(s)/PI(s) and conducted at the applicant institution, limited use of special facilities or equipment at another institution is permitted. For any proposed research sites other than the applicant institution, provide a brief description of the resources and access students will need and have to these resources.

    SF424(R&R) Senior/Key Person Profile

    All instructions in the SF424 (R&R) Application Guide must be followed.

    Biographical Sketch:  The PD(s)/PI(s) should include a summary of his or her previous and/or current experience supervising health professional, undergraduate and/or graduate students in research in the Personal Statement. The PD(s)/PI(s) should indicate which peer-reviewed publications or other research products involved health professional, undergraduate and/or graduate students under his or her supervision.

    R&R or Modular Budget

    All instructions in the SF424 (R&R) Application Guide must be followed.

    Modular Budget (direct costs of $250,000 or less):

    All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

    Budget Period 1: Direct Costs

    Direct Costs less Consortium F&A: Select the appropriate dollar amount from the drop-down list. This number must not exceed $250,000.

    Budget Justification:

    Personnel Justification: Since a primary objective of the REAP is to engage health professional, undergraduate and/or graduate students in meritorious research, the research team must be composed primarily of health professional, undergraduate and/or graduate students from the applicant institution/REAP-eligible component. Indicate aspects of the proposed research in which students will participate. If participating students have not yet been individually identified, the number and academic level of those to be involved should be provided. If there are any Collaborators or Consultants for the project, provide their names, organizational affiliations, and the services they will perform.

    R&R Budget (direct costs of $250,001 to $300,000):

    All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

    Budget Period 1: Direct Costs

    Total Direct Costs less Consortium F&A: This number must not exceed $300,000.

    Budget Justification:

    Personnel Justification: Since a primary objective of the REAP is to expose students to meritorious research, PD(s)/PI(s) must include health professional, undergraduate and/or graduate students from the applicant institution/applicant component in the proposed research. Indicate aspects of the proposed research in which students will participate. If participating students have not yet been individually identified, the number and academic level of those to be involved should be provided. If there are any Collaborators or Consultants for the project, provide their names, organizational affiliations, and the services they will perform.

    R&R Subaward Budget

    All instructions in the SF424 (R&R) Application Guide must be followed.

    PHS 398 Cover Page Supplement

    All instructions in the SF424 (R&R) Application Guide must be followed.

    PHS 398 Research Plan

    All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

    Research Strategy: Describe how the proposed plan can achieve the specific aims using a research team composed primarily of health professional, undergraduate and/or graduate students. Describe how students will be engaged in and supervised in conducting hands-on, rigorous research. Describe how students will participate in research activities such as planning, execution, and/or analysis of the research. Describe any other plans for student involvement, such as presentation at local or national meetings, participation in publication of research findings and development of, or participation in, collaborative activities. Formal training plans (e.g., non-research activities, didactic training, seminars) should not be provided, although a brief description of activities related to enhancing students' research capabilities and progress (e.g., the use of individual development plans, etc.) is permitted.

    Progress Report Publication List: For renewals, when listing publications, manuscripts accepted for publication, patents, and other printed materials that have resulted from the project, note which of these products have included the work of students conducting research supported by the REAP grant.

    Letters of Support: The application must include a PDF-formatted letter named "ProvostLetter.pdf" (without quotation marks). For MPI applications a signed Provost letter is required from each involved institution. The letter must be signed by the Provost or similar official with institution-wide responsibility attesting to the following information:

      •  
    • The eligible academic component(s) (i.e., the college/school level) must be a health professional or graduate school that awards health professional baccalaureate or advanced degrees in biomedical and/or biobehavioral sciences.
    • All components of the institution together have received support from the NIH totaling no more than $6 million per year (in both direct and F&A/indirect costs) in 4 of the last 7 years, as described in Section III, "Eligible Organization
    • Validation that the PD(s)/PI(s) has (or in the case of a multiple PD/PI application that all PD(s)/PI(s) have) a primary appointment at the qualifying component (i.e., the college/school level).

    Applications that do not contain this signed letter will be withdrawn without review.

    Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the SF424 (R&R) Application Guide.

    Appendix:
    Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.
    PHS Human Subjects and Clinical Trials Information

    When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the SF424 (R&R) Application Guide, with the following additional instructions:

    If you answered “Yes” to the question “Are Human Subjects Involved?” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.

    Study Record: PHS Human Subjects and Clinical Trials Information

    All instructions in the SF424 (R&R) Application Guide must be followed.

    Delayed Onset Study

    Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start).All instructions in the SF424 (R&R) Application Guide must be followed.

    PHS Assignment Request Form

    All instructions in the SF424 (R&R) Application Guide must be followed.

    3. Unique Entity Identifier and System for Award Management (SAM)

    See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov

    4. Submission Dates and Times

    Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday, the application deadline is automatically extended to the next business day.

    Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time.  If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.

    Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.

    Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.

    5. Intergovernmental Review (E.O. 12372)

    This initiative is not subject to intergovernmental review.

    6. Funding Restrictions

    All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

    Pre-award costs are allowable only as described in the NIH Grants Policy Statement.

    7. Other Submission Requirements and Information

    Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide.  Paper applications will not be accepted.

    Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

    For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply – Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.

    Important reminders:

    All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. See Section III of this FOA for information on registration requirements.

    The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the System for Award Management. Additional information may be found in the SF424 (R&R) Application Guide.

    See more tips for avoiding common errors.

    Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review, NIH. Applications that are incomplete or non-compliant will not be reviewed.

    Post Submission Materials

    Applicants are required to follow the instructions for post-submission materials, as described in the policy. Any instructions provided here are in addition to the instructions in the policy.

    Section V. Application Review Information

    1. Criteria

    Only the review criteria described below will be considered in the review process.  Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.

    For this particular announcement, note the following:

    This FOA has three objectives: (1) provide support for meritorious research at health professional or graduate institutions or institutional components; (2) strengthen the research environment at these institutions/components; and (3) give health professional, undergraduate and/or graduate students an opportunity to gain significant biomedical research experience through active involvement in the research. 

    The scientific foundation for the proposed research should be established using preliminary data (if available) and/or published data. Although preliminary data are not required for an R15 application, they may be included if available.

    Health professional, graduate, and/or undergraduate students in health professional schools as well as graduate and/or undergraduate students in graduate schools, pursuing biomedical or behavioral research, must be included in the research team. Any combination of health professional, graduate and/or graduate students from PIs’ institutions is allowed on the research team.

    Overall Impact

    Reviewers will provide an overall impact score to reflect their assessment of the likelihood for the project to make important scientific contributions to the research field(s) involved, to provide research opportunities to health professional, undergraduate and/or graduate students by engaging them in primary research activities, and to strengthen the research environment of the institution, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).

    Scored Review Criteria

    Reviewers will consider each of the review criteria below in relation to the REAP program objectives and give a separate score for each. An application does not need to be strong in all categories to be judged as a high impact REAP application. For example, a solid and interesting scientific research project that is not by its nature innovative or paradigm-shifting, and includes a good plan to engage health professional, graduate, and/or undergraduate students in primary research may be considered a strong, high impact REAP application.

    Significance

    Does the project address an important problem or a critical barrier to progress in the field? Is the prior research that serves as the key support for the proposed project rigorous? If the aims of the project are achieved,

    If the aims of the project are achieved, will the data be publishable, disseminated, and important to the field? If funded, will the REAP grant have a substantial effect on the applicant institution in terms of strengthening the research environment and exposing students to research?

    Investigator(s)

    Are the PD(s)/PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or those in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?

    Do the PD(s)/PI(s) have suitable experience in supervising and engaging health professional, undergraduate and/or graduate students in research? 

    Innovation

    Does the application take advantage of, challenge or build on current research concepts and models or research techniques? Are innovative approaches to engaging health professional, undergraduate and/or graduate students in research proposed?

    Approach

    Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Have the investigators included plans to address weaknesses in the rigor of prior research that serves as the key support for the proposed project? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? Have the investigators presented adequate plans to address relevant biological variables, such as sex, for studies in vertebrate animals or human subjects?

    If the project involves human subjects and/or NIH-defined clinical research, are the plans to address 1) the protection of human subjects from research risks, and 2) inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion or exclusion of individuals of all ages (including children and older adults), justified in terms of the scientific goals and research strategy proposed?

    Does the application provide sufficient evidence that the project can stimulate the interests of students so that they consider a career in the biomedical or behavioral sciences?

    Environment

    Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Does the application demonstrate the likely availability of well-qualified students to participate in the research project? Does the application demonstrate appropriate plans to recruit well-qualified health professional, undergraduate and/or graduate students from diverse backgrounds, including those from groups underrepresented in the biomedical research workforce (See NOT-OD-20-031) to participate in the research project? Does the application provide sufficient evidence that students at the REAP-eligible institution/academic component have in the past and/or are likely in the future to pursue careers in the biomedical sciences? Does the PD/PI(s) have sufficient time and institutional support to conduct the proposed project?

    Additional Review Criteria

    As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact score, but will not give separate scores for these items.

    Protections for Human Subjects

    For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.

    For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.

    Inclusion of Women, Minorities, and Individuals Across the Lifespan

    When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of individuals of all ages (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.

    Vertebrate Animals

    The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.

    Biohazards

    Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.

    Resubmissions

    For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

    Renewals

    For Renewals, the committee will consider the progress made in the last funding period, as well as whether the application provides sufficient evidence that health professional, undergraduate and/or graduate students have been included in publications in the past.

    Revisions

    For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.

    Additional Review Considerations

    As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact score.

    Applications from Foreign Organizations

    Not Applicable.

    Select Agent Research

    Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).

    Resource Sharing Plans

    Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: (1) Data Sharing Plan; (2) Sharing Model Organisms; and (3)  Genomic Data Sharing Plan (GDS).

    Authentication of Key Biological and/or Chemical Resources:

    For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources.

    Budget and Period of Support

    Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.

    2. Review and Selection Process

    Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by the Center for Scientific Review, in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

    As part of the scientific peer review, all applications will receive a written critique.

    Applications may undergo a selection process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review) will be discussed and assigned an overall impact score.

    Applications will be assigned on the basis of established PHS referral guidelines to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the appropriate national Advisory Council or Board. The following will be considered in making funding decisions:
    • Scientific and technical merit of the proposed project as determined by scientific peer review.
    • Availability of funds.
    • Relevance of the proposed project to program priorities.

    3. Anticipated Announcement and Award Dates

    After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons. Refer to Part 1 for dates for peer review, advisory council review, and earliest start date.

    Information regarding the disposition of applications is available in the NIH Grants Policy Statement.

    Section VI. Award Administration Information

    1. Award Notices

    If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement.

    A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the recipient's business official.

    Recipients must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.

    Any application awarded in response to this FOA will be subject to terms and conditions found on the Award Conditions and Information for NIH Grants website.  This includes any recent legislation and policy applicable to awards that is highlighted on this website.

    Institutional Review Board or Independent Ethics Committee Approval: Recipient institutions must ensure that protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the recipient must provide NIH copies of documents related to all major changes in the status of ongoing protocols.

    2. Administrative and National Policy Requirements

    All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Recipients, and Activities, including of note, but not limited to:

    If a recipient is successful and receives a Notice of Award, in accepting the award, the recipient agrees that any activities under the award are subject to all provisions currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

    Recipients of federal financial assistance (FFA) from HHS must administer their programs in compliance with federal civil rights laws that prohibit discrimination on the basis of race, color, national origin, disability, age and, in some circumstances, religion, conscience, and sex. This includes ensuring programs are accessible to persons with limited English proficiency. The HHS Office for Civil Rights provides guidance on complying with civil rights laws enforced by HHS. Please see https://www.hhs.gov/civil-rights/for-providers/provider-obligations/index.html and http://www.hhs.gov/ocr/civilrights/understanding/section1557/index.html.

    HHS recognizes that research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator’s scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research. For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA.

    Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws at https://www.hhs.gov/ocr/about-us/contact-us/index.html or call 1-800-368-1019 or TDD 1-800-537-7697.

    In accordance with the statutory provisions contained in Section 872 of the Duncan Hunter National Defense Authorization Act of Fiscal Year 2009 (Public Law 110-417), NIH awards will be subject to the Federal Awardee Performance and Integrity Information System (FAPIIS) requirements. FAPIIS requires Federal award making officials to review and consider information about an applicant in the designated integrity and performance system (currently FAPIIS) prior to making an award. An applicant, at its option, may review information in the designated integrity and performance systems accessible through FAPIIS and comment on any information about itself that a Federal agency previously entered and is currently in FAPIIS. The Federal awarding agency will consider any comments by the applicant, in addition to other information in FAPIIS, in making a judgement about the applicant’s integrity, business ethics, and record of performance under Federal awards when completing the review of risk posed by applicants as described in 45 CFR Part 75.205 and 2 CFR Part 200.206 “Federal awarding agency review of risk posed by applicants.” This provision will apply to all NIH grants and cooperative agreements except fellowships.

    Cooperative Agreement Terms and Conditions of Award

    Not Applicable

    3. Reporting

    Progress reports for multi-year funded awards are due annually on or before the anniversary of the budget/project period start date of award. The reporting period for multi-year funded award progress report is the calendar year preceding the anniversary date of the award. Information on the content of the progress report and instructions on how to submit the report using the RPPR are posted at http://grants.nih.gov/grants/policy/myf.htm

    A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement. NIH FOAs outline intended research goals and objectives. Post award, NIH will review and measure performance based on the details and outcomes that are shared within the RPPR, as described at 45 CFR Part 75.301 and 2 CFR Part 200.301.

    The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for recipients of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later.  All recipients of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000.  See the NIH Grants Policy Statement for additional information on this reporting requirement.

    In accordance with the regulatory requirements provided at 45 CFR 75.113 and Appendix XII to 45 CFR Part 75, recipients that have currently active Federal grants, cooperative agreements, and procurement contracts from all Federal awarding agencies with a cumulative total value greater than $10,000,000 for any period of time during the period of performance of a Federal award, must report and maintain the currency of information reported in the System for Award Management (SAM) about civil, criminal, and administrative proceedings in connection with the award or performance of a Federal award that reached final disposition within the most recent five-year period.  The recipient must also make semiannual disclosures regarding such proceedings. Proceedings information will be made publicly available in the designated integrity and performance system (currently FAPIIS).  This is a statutory requirement under section 872 of Public Law 110-417, as amended (41 U.S.C. 2313).  As required by section 3010 of Public Law 111-212, all information posted in the designated integrity and performance system on or after April 15, 2011, except past performance reviews required for Federal procurement contracts, will be publicly available.  Full reporting requirements and procedures are found in Appendix XII to 45 CFR Part 75 – Award Term and Conditions for Recipient Integrity and Performance Matters.

    Section VII. Agency Contacts

    We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

    Application Submission Contacts

    eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)

    Finding Help Online: http://grants.nih.gov/support/ (preferred method of contact)
    Telephone: 301-402-7469 or 866-504-9552 (Toll Free)

    General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources)
    Email: GrantsInfo@nih.gov (preferred method of contact)
    Telephone: 301-945-7573

    Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace)
    Contact Center Telephone: 800-518-4726
    Email: support@grants.gov

    Scientific/Research Contact(s)

    Contacts:

    Lisa Chadwick
    National Human Genome Research Institute (NHGRI)
    Phone: 301-435-7275
    E-mail: lisa.chadwick@nih.gov
     

    Astrid Haugen, M.S.E.H.
    National Institute of Environmental Health Sciences (NIEHS)
    Phone: 984-287-3266
    E-mail: haugen@mail.nih.gov
     

    Miguel A. Contreras, Ph.D.
    Office of Research Infrastructure Programs (ORIP)
    Phone: 301-594-9410
    E-mail: contre1@mail.nih.gov

    Lanay M. Mudd, Ph.D., FACSM
    National Center for Complementary and Integrative Health (NCCIH)
    Phone: 301-594-9346
    Email: lanay.mudd@nih.gov
     

    Aaron D Laposky
    National Heart, Lung, And Blood Institute (NHLBI)
    Phone: 301-827-7837
    E-mail: laposkya@mail.nih.gov
     

    Gerald McLaughlin, Ph.D.
    National Institute On Drug Abuse (NIDA)
    Phone: 301-827-5819
    E-mail: mclaughlin@nida.nih.gov
     

    Cheri Wiggs
    National Eye Institute (NEI)
    Phone: (301) 402-0276
    E-mail: cheri.wiggs@nih.gov
     

    Rene Etcheberrigaray, M.D.
    National Institute on Aging (NIA)
    Phone: 301-451-9798
    Email: rene.etcheberrigaray@nih.gov
     

     

    Aileen Schulte, Ph.D.
    National Institute of Mental Health (NIMH)
    Phone: 301-443-1225
    Email: aschulte@mail.nih.gov

    Susan L Sullivan, Ph.D.
    National Institute On Deafness And Other Communication Disorders (NIDCD)
    Phone: 301-496-8683
    E-mail: sullivas@nidcd.nih.gov
     

    Li Lin, Ph.D.
    National Institute On Alcohol Abuse And Alcoholism (NIAAA)
    Phone: 301-827-7749
    E-mail: linli@mail.nih.gov
     

    Mahua Mukhopadhyay, Ph.D.
    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Phone: 301-435-6886
    Email: mukhopam@mail.nih.gov
     

    Lynn King, PhD
    National Institute Of Dental & Craniofacial Research (NIDCR)
    Phone: 301-594-5006
    E-mail: lynn.king@nih.gov
     

    Kristy Nicks, PhD
    National Institute Of Arthritis And Musculoskeletal And Skin Diseases (NIAMS)
    Phone: (301) 594-5055
    E-mail: kristy.nicks@nih.gov
     

    Diane Adger-Johnson, MPH
    National Institute of Allergy and Infectious Diseases (NIAID)
    Telephone:  240-669-2924
    Email:  AITrainingHelpDesk@niaid.nih.gov
     

     

    Liz Perruccio, MS, PhD
    National Institute of Nursing Research (NINR)
    Telephone: 301-402-8084
    Email: liz.perruccio@nih.gov

     

    Tina Gatlin, Ph.D.
    National Institute Of Biomedical Imaging And Bioengineering (NIBIB)
    Phone: 301-480-1608
    E-mail: christine.gatlin@nih.gov
     

    Delany Torres, Ph.D.
    National Institute of Neurological Disorders and Stroke (NINDS)
    Telephone: 301-402-9286
    Email: delany.torressalazar@nih.gov
     

    Biman C. Paria, Ph.D., MS (Reg. Sc)
    National Cancer Institute (NCI)
    Email:  ncirefof@dea.nci.nih.gov

    Carolina Solis-Sanabria, Ph.D.
    Telephone: 301.827.3462
    Email: carolina.solissanabria@nih.

    Peer Review Contact(s)

    Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

    General R15-Related Review Questions:

    Svetlana E. Kotliarova, PhD
    Center for Scientific Review (CSR)
    Telephone: 301-594-7945
    Email: kotiars@csr.nih.gov

    Financial/Grants Management Contact(s)

    Contacts:

    Deanna L Ingersoll
    National Human Genome Research Institute (NHGRI)
    Phone: 301-435-7858
    E-mail: deanna.ingersoll@nih.gov
     

    Lisa A Edwards, MBA
    National Institute of Environmental Health Sciences (NIEHS)
    Phone: 984-287-3258
    E-mail: archer@niehs.nih.gov
     

    Shelley Headley
    National Center for Complementary and Integrative Health (NCCIH)
    Phone: 301-594-3788
    Email: shelley.headley@nih.gov
     

    Ryan Lombardi
    National Heart, Lung, And Blood Institute (NHLBI)
    Phone: (301) 435-0141
    E-mail: rl116q@nih.gov
     

    Pamela G Fleming
    National Institute On Drug Abuse (NIDA)
    Phone: 301-480-1159
    E-mail: pfleming@mail.nih.gov
     

    Karen Robinsonsmith
    National Eye Institute (NEI)
    Phone: (301) 451-2020
    E-mail: kyr@nei.nih.gov
     

    Ryan Blakeney
    National Institute on Aging (NIA)
    Phone: 301-451-9802
    Email: blakeneyr@mail.nih.gov
     

     

    Terri Jarosik
    National Institute of Mental Health (NIMH)
    Telephone: 301-443-3858
    Email: tjarosik@mail.nih.gov

    Christopher Myers
    National Institute On Deafness And Other Communication Disorders (NIDCD)
    Phone: (301) 435-0713
    E-mail: myersc@nidcd.nih.gov
     

    Judy Fox
    National Institute On Alcohol Abuse And Alcoholism (NIAAA)
    Phone: (301) 443-4704
    E-mail: jfox@mail.nih.gov
     

    Margaret Young
    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Phone: 301-642-4552
    Email: margaret.young@nih.gov 

    Diana Rutberg, MBA
    National Institute Of Dental & Craniofacial Research (NIDCR)
    Phone: (301) 594-4798
    E-mail: dr258t@nih.gov
     

    Teresa Do
    National Institute Of Arthritis And Musculoskeletal And Skin Diseases (NIAMS)
    Phone: (301) 594-3512
    E-mail: td118m@nih.gov
     

    Annie Grimes
    National Institute of Allergy and Infectious Diseases (NIAID)
    Telephone: 301-761-7315
    Email: Annie.grimes@nih.gov
     

    Ron Wertz
    National Institute of Nursing Research (NINR)
    Telephone: 301-594-2807
    Email: wertzr@mail.nih.gov

     

    Chief Grants Management Officer
    National Institute of Neurological Disorders and Stroke (NINDS)
    Email: ChiefGrantsManagementOfficer@ninds.nih.gov  
     

    Crystal Wolfrey 
    National Cancer Institute (NCI)
    Telephone: 240-276-6277
    Email: wolfreyc@mail.nih.gov 

    Section VIII. Other Information

    Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

    Authority and Regulations

    Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75.

    NIH Office of Extramural Research Logo
    Department of Health and Human Services (HHS) - Home Page
    Department of Health
    and Human Services (HHS)
    USA.gov - Government Made Easy
    NIH... Turning Discovery Into Health®


    Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.